Table 2.
Comparison of Goal Achievement of Adherence, by Baseline Adherence Status and Type of Antipsychotic Drug
| Adherence status at baseline, N (%) | |||||||
|---|---|---|---|---|---|---|---|
| All patients | Baseline PDC ≥0.8 | Baseline PDC <0.8 | |||||
| Patients | All users, N | Achievers,a N (%) | All users, N | Achievers,a N (%) | All users, N | Achievers,a N (%) | P valueb |
| Paliperidone palmitate users | 492 | 228 (46.3) | 197 | 150 (76.1) | 295 | 78 (26.4) | <.0001 |
| Other antipsychotic drug users | 12,498 | 6088 (48.7) | 5459 | 4161 (76.2) | 7039 | 1927 (27.4) | <.0001 |
| Total | 12,990 | 6316 (48.6) | 5656 | 4311 (76.2) | 7334 | 2005 (27.3) | <.0001 |
| Type of antipsychotic drug users at baseline, N (%) | |||||||
| All patients | Paliperidone palmitate users | Other antipsychotics users | |||||
| PDC | All users, N | P valueb | Achievers,a N (%) | All users, N | Achievers,a N (%) | All users, N | Achievers,a N (%) |
| Baseline PDC ≥0.8 | 5656 | 4311 (76.2) | 197 | 150 (76.1) | 5459 | 4161 (76.2) | .9792 |
| Baseline PDC <0.8 | 7334 | 2005 (27.3) | 295 | 78 (26.4) | 7039 | 1927 (27.4) | .7240 |
| Total | 12,990 | 6316 (48.6) | 492 | 228 (46.3) | 12,498 | 6088 (48.7) | .3022 |
a
Achievers were identified as patients with a PDC ≥80% during the measurement year.
b
Statistical differences between cohorts were calculated using chi-square tests.
PDC indicates proportion of days covered.